Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.75
+0.06 (0.36%)
At close: Jan 16, 2026, 4:00 PM EST
16.53
-0.22 (-1.31%)
After-hours: Jan 16, 2026, 5:40 PM EST
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $917.6 million as of January 16, 2026. Its market cap has decreased by -3.20% in one year.
Market Cap
917.60M
Enterprise Value
629.41M
1-Year Change
-3.20%
Ranking
Category
Stock Price
$16.75
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $917.60M, a decrease of -1.51%. That is a compound annual growth rate of -1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 917.60M | -0.48% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.72B |
| Johnson & Johnson | 528.44B |
| AbbVie | 382.64B |
| UnitedHealth Group | 303.15B |
| AstraZeneca | 291.28B |
| Novartis AG | 273.64B |
| Merck & Co. | 271.78B |
| Novo Nordisk | 252.12B |